Natera
The Senior Director of Development leads product development strategy and execution for Natera's Early Cancer Detection and Multi-Cancer Early Detection portfolio. This role guides Next-Generation Sequencing and cell-free DNA-based In Vitro Diagnostic products from feasibility through FDA Premarket Approval and post-market support. The position involves building and mentoring a leadership team, allocating resources, and representing development with the FDA and executive leadership.
Headquarters
Austin, Texas, United States
Company Size
1001-5000 employees
Founded
2004
Natera is a molecular diagnostics company that develops and commercializes cell-free DNA testing for oncology, women's health, organ health, and rare disease. Its tests are used for cancer detection and monitoring, noninvasive prenatal and carrier screening, transplant rejection assessment, and genomic analysis for rare diseases. Natera's clinically validated tests are processed in CAP/CLIA-certified labs and supported by over 400 peer-reviewed publications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Natera.
Natera's 1.18% Stock Decline Despite $280M Volume Surge Ranks 429th in Trading Activity
14 hours ago
Staff Scientist, IVD Assay Verification and Validation
DELFI Diagnostics, Inc.
Director of Regulatory Affairs
Element Biosciences
Principal Regulatory Affairs
Hamilton Medical, Inc.
Regulatory Affairs Specialist – FDA
IMMY
Regulatory Affairs Engineering Lead - Skin Program
Neko Health
Quality Engineer Level 3 – Risk Management
Oracle